Fast Five Quiz: Angina

Yasmine S. Ali, MD


August 27, 2021

Chronic stable angina treatment involves lifestyle and risk factor modifications in addition to medical therapy. Nitrates are considered first-line treatment for patients with stable angina. However, their use is contraindicated in patients with chronic stable angina who have taken phosphodiesterase inhibitors within the past 48 hours and in patients with hypotension.

Beta-blockers and calcium channel blockers are also recognized as first-line treatment options for patients with chronic stable angina. They are recommended in patients with previous MI and in those with reduced left ventricle ejection fraction less than 40%. Avoid combining beta-blockers and nondihydropyridine calcium channel blockers. Second-line treatments include ranolazine, ivabradine, and nicorandil. Allopurinol has been used as a second- or third-line agent for symptom control.

Read more about the treatment of angina.

This Fast Five Quiz was excerpted and adapted from the Medscape Drugs & Diseases articles Angina Pectoris, Unstable Angina, and Coronary Artery Vasospasm.

Follow Medscape on Facebook, Twitter, Instagram, and YouTube


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.